Dr. John Mann: Special Reports, Psychiatric Times

There has been much debate about whether certain classes of medications (eg, antidepressants) increase the risk of suicidal behavior and whether that risk is greater in children, adolescents, and young adults. In 2004, the FDA placed a black box warning on all antidepressants because of concerns that the medications increase risk of suicidal thoughts and behavior in youths; in 2006, the warning was extended to include young adults (up to age 26). The FDA based its black box warning on results of its meta-analyses of randomized controlled trials (RCTs) conducted in pediatric and adult psychiatric and nonpsychiatric populations. - See more at: http://www.psychiatrictimes.com/relationship-between-antidepressant-initiation-and-suicide-risk#sthash.ABBA4m8m.dpuf
Read more:  http://www.psychiatrictimes.com/relationship-between-antidepressant-initiation-and-suicide-risk